Basilea wins CARB-X grant for new antibody development
The grant will support the preclinical development of the antibody acquired by Basilea from Spexis in January 2024.
Mimotopes Early R&D projects
Bayer and Broad Institute extend cancer therapy development programme
Prelude and AbCellera jump on the ADC train with partnership
Gilead and Assembly Biosciences partner to develop antiviral therapies
Researchers publish early results with new interleukin-targeting antibody
SK bioscience and Doherty Institute partner on flu vaccine research
Psylo signs research deal with Daiichi Sankyo for psychiatric therapies
Cholesgen and AstraZeneca to advance research in hypercholesterolemia
